{"status": "Ok", "redirect_url": "https://www.investor.jnj.com/investor-news/news-details/2026/Johnson--Johnson-investigational-co-antibody-therapy-JNJ-4804-shows-potential-to-raise-the-bar-for-clinical-efficacy-in-treating-refractory-inflammatory-bowel-disease/default.aspx", "message": "News view counter 703068 successfully enlarged"}